✦ LIBER ✦

Treatment of T3B prostate cancer with a combination of hormonal therapy, permanent brachytherapy and external beam irradiation

✍ Scribed by Vassilios M. Skouteris; Nelson N. Stone; Jamie A. Cesaretti; Richard G. Stock

Book ID: 108074910
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 61 KB
Volume: 7
Category: Article
ISSN: 1538-4721
DOI: 10.1016/j.brachy.2008.02.451

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Update on the treatment of prostate canc

Update on the treatment of prostate cancer with external beam irradiation

✍ Horwitz, Eric M.; Hanlon, Alexandra L.; Hanks, Gerald E. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB 👁 2 views

## Background: We review the recent changes in the radiotherapeutic management of clinically localized prostate cancer, including the implementation of three-dimensional (3-d) conformal radiation therapy (3dcrt), biochemical disease-free survival (bned control) using conventional and 3dcrt techniqu

High-dose-rate brachytherapy in combinat

High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer

✍ Daniel R. Zwahlen; Nick Andrianopoulos; Bronwyn Matheson; Gillian M. Duchesne; J 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 266 KB

The impact of prostate volume changes du

The impact of prostate volume changes during external-beam irradiation in consequence of HDR brachytherapy in prostate cancer treatment

✍ Markus Karl Alfred Herrmann; Tammo Gsänger; Arne Strauss; Tereza Kertesz; Hendri 📂 Article 📅 2009 🏛 Springer 🌐 German ⚖ 302 KB

Health-related quality of life and treat

✍ Katsuyoshi Hashine; Kouji Azuma; Takahiro Koizumi; Yoshiteru Sumiyoshi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 301 KB

Preliminary toxicity and prostate-specif

Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer•

✍ Richard G Stock; Nelson N Stone 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Late toxicity and biochemical recurrence

Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy : Analysis of Radiation Therapy Oncology Group study 0019

✍ W. Robert Lee; Kyoungwha Bae; Colleen Lawton; Michael Gillin; Gerard Morton; Sel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Abstract ## BACKGROUND The combination of external‐beam radiotherapy and brachytherapy is used commonly to treat men with prostate cancer. In this analysis, the authors examined the rate of biochemical recurrence (BR) and late grade ≥3 genitourinary (GU) and gastrointestinal (GI) toxicity after